Toshiaki Iba
#148,612
Most Influential Person Now
Researcher ORCID ID = 0000-0002-0255-4088
Toshiaki Iba's AcademicInfluence.com Rankings
Toshiaki Ibacomputer-science Degrees
Computer Science
#7645
World Rank
#8049
Historical Rank
Artificial Intelligence
#3184
World Rank
#3231
Historical Rank
Database
#4697
World Rank
#4880
Historical Rank
Download Badge
Engineering Computer Science
Toshiaki Iba's Degrees
- PhD Engineering Kyushu University
- Masters Engineering Kyushu University
- Bachelors Engineering Kyushu University
Similar Degrees You Can Earn
Why Is Toshiaki Iba Influential?
(Suggest an Edit or Addition)Toshiaki Iba's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 (2020) (1544)
- [Disseminated intravascular coagulation]. (2003) (1205)
- Coagulation abnormalities and thrombosis in patients with COVID-19 (2020) (1109)
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 (2020) (498)
- A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria* (2006) (487)
- Coagulopathy of Coronavirus Disease 2019 (2020) (370)
- The unique characteristics of COVID-19 coagulopathy (2020) (342)
- Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation (2019) (283)
- Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis (2018) (276)
- Coagulopathy in COVID‐19 (2020) (268)
- The coagulopathy, endotheliopathy, and vasculitis of COVID-19 (2020) (252)
- Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey* (2008) (213)
- Expert consensus for the treatment of disseminated intravascular coagulation in Japan. (2010) (209)
- New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey (2017) (204)
- Derangement of the endothelial glycocalyx in sepsis (2019) (155)
- A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis (2013) (130)
- Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation (2019) (127)
- DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. (2016) (121)
- ALTERATIONS IN COAGULATION AND FIBRINOLYSIS DURING SEPSIS (1996) (106)
- Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation (2019) (100)
- Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism (2014) (98)
- The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020) (2021) (87)
- The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016) (2018) (86)
- Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model (2005) (83)
- Evaluation of New Japanese Diagnostic Criteria for Disseminated Intravascular Coagulation in Critically Ill Patients (2005) (82)
- Neutrophil cell death in response to infection and its relation to coagulation (2013) (75)
- Proposal of the Definition for COVID-19-Associated Coagulopathy (2021) (72)
- Anticoagulant therapy for sepsis‐associated disseminated intravascular coagulation: the view from Japan (2014) (71)
- ASSOCIATION BETWEEN THE SEVERITY OF SEPSIS AND THE CHANGES IN HEMOSTATIC MOLECULAR MARKERS AND VASCULAR ENDOTHELIAL DAMAGE MARKERS (2005) (71)
- The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG 2016) (2018) (70)
- Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction (2015) (68)
- Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy (2018) (68)
- The role of the endothelium in changes in procoagulant activity in sepsis. (1998) (66)
- Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential (2019) (65)
- Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey. (2012) (64)
- SIRS-ASSOCIATED COAGULOPATHY AND ORGAN DYSFUNCTION IN CRITICALLY ILL PATIENTS WITH THROMBOCYTOPENIA (2007) (64)
- Tissue Plasminogen Activator Expression in Endothelial Cells Exposed to Cyclic Strain in Vitro (1992) (63)
- Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis. (2009) (61)
- Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey (2014) (55)
- Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH (2019) (55)
- Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria (2008) (55)
- Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model (2009) (54)
- Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers. (2007) (54)
- COVID-19 coagulopathy: is it disseminated intravascular coagulation? (2020) (53)
- ISTH DIC subcommittee communication on anticoagulation in COVID‐19 (2020) (52)
- Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure (1995) (52)
- Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan (2016) (50)
- Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice. (2016) (49)
- COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health (2020) (48)
- Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections (2006) (45)
- COMPARISON OF THE PROTECTIVE EFFECTS OF TYPE III PHOSPHODIESTERASE (PDE3) INHIBITOR (CILOSTAZOL) AND ACETYLSALICYLIC ACID ON INTESTINAL MICROCIRCULATION AFTER ISCHEMIA REPERFUSION INJURY IN MICE (2006) (45)
- Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity (2016) (45)
- Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality (2020) (45)
- ISTH guidelines for antithrombotic treatment in COVID‐19 (2022) (45)
- Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy (2019) (44)
- Role of extracellular vesicles in the development of sepsis-induced coagulopathy (2018) (44)
- Is the neutrophil a ‘prima donna’ in the procoagulant process during sepsis? (2014) (42)
- Laparoscopic surgery for left paraduodenal hernia. (2004) (41)
- Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation (2014) (41)
- The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. (2019) (41)
- A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH (2018) (41)
- The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation. (2013) (40)
- Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation (2020) (40)
- Defining trauma‐induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH (2020) (39)
- Potential diagnostic markers for disseminated intravascular coagulation of sepsis. (2016) (38)
- Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan". (2014) (35)
- PRETREATMENT OF SIVELESTAT SODIUM HYDRATE IMPROVES THE LUNG MICROCIRCULATION AND ALVEOLAR DAMAGE IN LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INFLAMMATION IN HAMSTERS (2006) (35)
- Sepsis-associated disseminated intravascular coagulation and its differential diagnoses (2019) (35)
- Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis. (2018) (33)
- Laparoscopy-Assisted Low Anterior Resection with a Prolapsing Technique for Low Rectal Cancer (2005) (33)
- Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide (2017) (32)
- Factor Xa-Inhibitor (Dx-9065a) Modulates the Leukocyte-Endothelial Cell Interaction in Endotoxemic Rat (2002) (32)
- A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC (2018) (32)
- Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation (2016) (29)
- High-Dose Antithrombin Therapy for Sepsis: Mechanisms of Action (2002) (28)
- Antimicrobial cathelicidin peptide LL‑37 induces NET formation and suppresses the inflammatory response in a mouse septic model. (2017) (27)
- Frequency and hemostatic abnormalities in pre-DIC patients. (2010) (27)
- The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia (2021) (27)
- Recent advances in the research and management of sepsis-associated DIC (2021) (26)
- Type and dose of heparin in Covid‐19: Reply (2020) (26)
- Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin (2005) (25)
- Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats (2012) (25)
- Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic rats. (2014) (25)
- Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial (2017) (25)
- Antithrombin (1976) (25)
- The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation. (2015) (24)
- Recombinant thrombomodulin improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat LPS model. (2013) (24)
- Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021) (24)
- Combination of antithrombin and recombinant thrombomodulin attenuates leukocyte-endothelial interaction and suppresses the increase of intrinsic damage-associated molecular patterns in endotoxemic rats. (2014) (23)
- Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin (2018) (23)
- Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model. (2011) (23)
- Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats (2008) (21)
- Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation (2019) (21)
- ENOXAPARIN ATTENUATES ENDOTHELIAL DAMAGE WITH LESS BLEEDING COMPARED WITH UNFRACTIONATED HEPARIN IN ENDOTOXEMIC RATS (2009) (21)
- Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis (2019) (21)
- DIC in obstetrics: Diagnostic score, highlights in management, and international registry‐communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis (2019) (20)
- Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: a rebuttal. (2013) (20)
- Laboratory haemostasis monitoring in COVID‐19 (2020) (20)
- Rivaroxaban attenuates leukocyte adhesion in the microvasculature and thrombus formation in an experimental mouse model of type 2 diabetes mellitus. (2014) (20)
- COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations (2021) (20)
- Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation (2019) (20)
- Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis‐associated coagulopathy: A systematic review and meta‐analysis (2020) (19)
- Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk (2019) (19)
- Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation (2017) (18)
- Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide. (2017) (16)
- Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model. (2017) (16)
- The absence of typical pneumonia symptoms in a patient with rheumatoid arthritis during tocilizumab and steroid treatment (2012) (16)
- Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination (2022) (15)
- Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation. (2016) (15)
- The influence of hyperglycemia on neutrophil extracellular trap formation and endothelial glycocalyx damage in a mouse model of type 2 diabetes. (2020) (15)
- Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey (2017) (14)
- The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020) (2021) (14)
- Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? (2021) (14)
- DOACs and “newer” hemophilia therapies in COVID‐19: Reply (2020) (13)
- Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy (2021) (13)
- Role of DIC in multiple organ failure. (2000) (13)
- Ischemic limb necrosis in septic shock: What is the role of high‐dose vasopressor therapy? (2019) (13)
- Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation (2018) (13)
- Effect of Hemoperfusion Using Polymyxin B-immobilized Fibers on Acute Lung Injury in a Rat Sepsis Model (2014) (13)
- Multiple biomarkers of sepsis identified by novel time-lapse proteomics of patient serum (2019) (13)
- New therapeutic options for patients with sepsis and disseminated intravascular coagulation. (2014) (12)
- Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management (2022) (12)
- Neutrophil extracellular traps, damage‐associated molecular patterns, and cell death during sepsis (2014) (12)
- Antithrombin modulates the leukocyte-endothelial cell interaction in the staphylococcal enterotoxin B-challenged mouse. (2003) (12)
- Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis (2017) (12)
- Prothrombin Time Tests for the Monitoring of Direct Oral Anticoagulants and Their Evaluation as Indicators of the Reversal Effect (2017) (12)
- Selective hydrogenation of alkynes by hectorite-intercalated PD[II] complexes (1989) (12)
- Whole Body CT for a Patient with Sepsis (2013) (11)
- What can we learn from the three megatrials using anticoagulants in severe sepsis? (2004) (11)
- Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis (2020) (10)
- Physiological Levels of Pentraxin 3 and Albumin Attenuate Vascular Endothelial Cell Damage Induced by Histone H3 In Vitro (2016) (10)
- Comparison between British and Japanese guidelines for the diagnosis and treatment of disseminated intravascular coagulation (2010) (10)
- The Roles of Coagulation Disorder and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment. (2021) (9)
- Total parenteral nutrition supplemented with medium-chain triacylglycerols prevents atrophy of the intestinal mucosa in septic rats. (1998) (9)
- Kinetics of Circulating Damage-Associated Molecular Patterns in Sepsis (2015) (8)
- High-dose antithrombin therapy for sepsis. (2000) (8)
- DOACs and ‘newer’ haemophilia therapies in COVID-19 (2020) (8)
- Protective effect of a newly developed fucose-deficient recombinant antithrombin against histone-induced endothelial damage (2018) (8)
- Factor Xa inhibitor attenuates leukocyte adhesion and thrombus formation in an experimental mouse model of the metabolic syndrome. (2013) (8)
- Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils (2020) (8)
- Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation (2021) (8)
- The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro (2017) (8)
- The wind changed direction and the big river still flows: from EUPHRATES to TIGRIS (2019) (8)
- Significance of urinary incontinence, age, and consciousness level on arrival among patients with stroke (2013) (7)
- A case of cardiac arrest with ST elevation induced by contrast medium. (2012) (7)
- Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis (2020) (7)
- Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again (2020) (7)
- The role of platelets in heat-related illness and heat-induced coagulopathy. (2022) (7)
- Therapeutic strategies in patients with coagulopathy and disseminated intravascular coagulation: awareness of the phase-dependent characteristics. (2021) (7)
- Comparison of prothrombin time tests used in the monitoring of edoxaban and their evaluation as indicators of the reversal effect (2016) (7)
- The effect of plasma-derived activated protein C on leukocyte cell-death and vascular endothelial damage. (2015) (6)
- Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa (2021) (6)
- Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019 (2022) (6)
- Formation of the venous thrombus after venous occlusion in the experimental mouse model of metabolic syndrome. (2012) (6)
- Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together. (2021) (6)
- Predicting mortality in patients with disseminated intravascular coagulation after cardiopulmonary bypass surgery by utilizing two scoring systems (2019) (6)
- Protective Effects of Antithrombin III on Organ Dysfunction Induced by the Continuous Infusion of Endotoxin in Rats (1998) (6)
- Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations. (2022) (6)
- Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic (2021) (6)
- Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET (2018) (6)
- The meanings of DIC diagnostic criteria. (2012) (5)
- [The intratumoral levels of thymidylate synthetase and folate in gastric and colon cancer]. (1998) (5)
- Does TeamSTEPPS affect psychological status? (2019) (5)
- Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux (2016) (5)
- Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective? (2016) (5)
- Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study (2020) (5)
- Platelet Activation and Thrombosis in COVID-19 (2022) (5)
- The application of anticoagulant therapy to sepsis (2017) (5)
- [Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer]. (2003) (4)
- Characteristics of Severe Alcoholic Ketoacidosis with a Reversible Visual Disturbance (2012) (4)
- Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis (2020) (3)
- The efficacy of long-term oral chemotherapy with 5′-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer (2004) (3)
- Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers (2015) (3)
- Current status of venous thromboembolism development during the perioperative period for colorectal cancer, its prevention with enoxaparin, and monitoring methods (2019) (3)
- Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective? (2014) (3)
- Intracellular communication and immunothrombosis in sepsis (2022) (3)
- The authors reply. (2020) (3)
- Glycocalyx regulates the intravascular hemostasis (2016) (3)
- Analysis of non‐traumatic truncal back pain in patients who visited an emergency room (2014) (3)
- Reply to “Errors in the diagnosis for DIC due to a statistical misunderstanding” (2020) (2)
- [A case of gallbladder cancer with marked response to EAP treatment]. (1992) (2)
- Changes in Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Sepsis with Organ Failure (1994) (2)
- Antithrombin/danaparoid sodium combination therapy is effective for organ dysfunction induced by endotoxin (2004) (2)
- Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan (2013) (2)
- Intermittent low-dose cisplatin infusion as a possible modulator of 5-fluorouracil (1997) (2)
- Therapeutic Approach for Severe Sepsis Based on the Evidence 2007 (2008) (2)
- A case of paraparesis with thoracic ossification of the posterior longitudinal ligament and the ligamentum flavum induced by falling down on the abdomen (2014) (2)
- Improvement in Sinusoidal Circulation with Supplement of Antithrombin III in Endotoxemic Rats (1998) (2)
- The current status of the therapeutic approach for severe sepsis in Japan and its comparison to the international guidelines (2009) (2)
- Thrombosis and COVID-19: Controversies and (Tentative) Conclusions. (2021) (2)
- The obstacles that should be overcome to develop new anticoagulants for severe sepsis. (2014) (2)
- A CASE REPORT OF SPINDLE CELL CARCINOMA IN BILATERAL SYNCHRONOUS BREAST CANCER (1989) (2)
- Evaluation of a Rat Model for Disseminated Intravascular Coagulation Developed by Infusion of Lipopolysaccharide (1997) (2)
- ポリエーテルエーテルケトン、それを含有する樹脂組成物、およびその成形体 (2008) (1)
- Alterations in circulating levels of soluble intercellular adhesion molecule-1 in sepsis. (1997) (1)
- The Effect of Antithrombin III on Cytokine Production in Endotoxemic Rats (1999) (1)
- [Case of dyspnea due to toilet cleaner containing nitric acid for household use]. (2013) (1)
- Controversies regarding the use of antithrombin for sepsis-associated disseminated intravascular coagulation: an update of the evidence. (2015) (1)
- Morphological Changes in Blood Cells in a Rat Model of Heatstroke: A Pilot Study (2022) (1)
- Antithrombin III Effects on the Production of Vasoactive Substances in Endotoxemic Rats (1999) (1)
- Changes in Circulating Levels of Tissue Factor and Tissue Factor Pathway Inhibitor in SIRS, Septic MODS and Septic DIC (1997) (1)
- Imbalance between Coagulation and Fibrinolysis in Sepsis (1995) (1)
- Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation (2015) (1)
- [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil]. (1993) (1)
- [Four cases of advanced adenocarcinoma showing marked response to EAP (etoposide, ADM, CDDP) treatment]. (1993) (1)
- [Changes in folate levels after cisplatin treatment of gastric cancer]. (1996) (1)
- [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients]. (2001) (1)
- [Reliability of the lipid emulsion test for reticuloendothelial system]. (1989) (1)
- The comparison of British guidelines and Japanese guidelines for septic DIC (2009) (1)
- A case of Juvenile polyposis localized in the stomach accompanied by anemia and hypoproteinemia (2001) (1)
- Changes in Activated Protein C Levels in Severe Sepsis (1998) (1)
- Disaster Medicine Education and Training for Medical Student at Juntendo University (2014) (1)
- Activated protein C suppresses the production of pro-inflammatory cytokines and the leukocyte-endothelial interaction in rat LPS model (2005) (1)
- COVID-19-associated coagulopathy and thrombosis (2020) (1)
- [Activated protein C (the impact of PROWESS trial)]. (2004) (0)
- Clinical Elective Study Report at the Department of Emergency and Critical Care Medicine in Juntendo University Faculty of Medicine (2015) (0)
- The Unbalance of Coagulation/Fibrinolysis and Microcirculatory Disturbance in Sepsis (2000) (0)
- without Cell Activation Uptake by Liver Sinusoidal Endothelial Cells LL-37 Enhances the Lipopolysaccharide Human Host Defense Cathelicidin Peptide (2016) (0)
- Inflammation, coagulation, and cellular injury in heat-induced shock (2023) (0)
- Is protein C zymogen really ineffective for ALL cases of sepsis including septic DIC? (2016) (0)
- What's fishy about protamine? Clinical use, adverse reactions, and potential alternatives. (2023) (0)
- [The mechanism of biochemical modulation in methotrexate/5-fluorouracil sequential chemotherapy]. (1994) (0)
- IMPROVEMENT IN SINUSOIDAL CIRCULATION WITH SUPPLEMENT OF ANTITHROMBIN III IN ENDOTOXEMIC RATS.: 138 (1998) (0)
- Physiological protease inhibitors (2006) (0)
- [The modulation of intracellular folate level by leucovorin: preliminary report]. (1992) (0)
- RE: The prothrombin time ratio is not a more effective marker for evaluating sepsis‐induced coagulopathy than fibrin‐related markers: Response to the Letter‐to‐the‐Editor by Dr Wada (2020) (0)
- Conceptual change of the septic disseminated intravascular coagulation and the progress in its treatment (2011) (0)
- A new SOFA score calculation to improve the predictive performance for mortality in sepsis-associated disseminated intravascular coagulopathy patients. (2020) (0)
- Hypofibrinogenemia is Associated With a High Degree of Risk in Infectious and Hematological Diseases: A Post-Hoc Analysis of Post-Marketing Surveillance of Patients With Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa (2020) (0)
- [Pretreatment with cilostazol protects against the vascular endothelial damage after ischemia/reperfusion]. (2008) (0)
- The Current Status of Sepsis Research in Japan in Comparison to the Status of International Research (2010) (0)
- Lessons from the recent sepsis trials (2012) (0)
- SSCG 2012 preview (2012) (0)
- Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. (2023) (0)
- TCRM_A_201954 791..802 (2019) (0)
- Pitfalls in Diagnosing Vaccine-Induced Immune Thrombotic Thrombocytopenia. (2021) (0)
- [Comparison between continuous intravenous and oral administration of 5-FU with LV]. (1999) (0)
- Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019 (2023) (0)
- Scholarly publishing cannot fit to a regular business model (2013) (0)
- 130; CHANGES IN PLASMA LEVELS OF TISSUE PLASMINOGEN ACTIVATOR, and PLASMINOGEN ACTIVATOR INHIBITOR 1 IN SEPSIS WITH ORGAN FAILURE (1994) (0)
- The current status of sepsis research in Japan and its international comparison (2010) (0)
- Concerns regarding meta-analysis and RCT selection about anticoagulants to treat sepsis-associated disseminated intravascular coagulation in the Japanese Surviving Sepsis Campaign Guidelines 2020 (2022) (0)
- Development of a Pulse-tube Refrigerator for the Competition (2017) (0)
- A Case of Severe Methicillin Resistant Staphylococcus Aureus Enterocolitis. (1992) (0)
- Glycocalyx damage and microcirculatory disturbance (2019) (0)
- Perioperative Anaphylaxis (2022) (0)
- COMPARISON OF THE PROTECTIVE EFFECTS OF CILOSTAZOL AND ACETYLSALICYLIC ACID ON INTESTINAL MICROCIRCULATION AFTER ISCHEMIA REPERFUSION INJURY (2006) (0)
- THREE CASES OF HETEROTOPIC BONE FORMATION IN LAPAROTOMY SCARS (1987) (0)
- [Recent trends in laparoscopic surgery for right side colon cancer]. (2003) (0)
- Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasias on vascular endothelium-related biomarkers in disseminated intravascular coagulation. (2022) (0)
- The Management of Post-surgical Acute Lung Injury—A Summary of Pharmacologic Treatment— (2007) (0)
- A Case of Lung Lesions Induced by a soccer Ball (2013) (0)
- Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer (2022) (0)
- [Revisiting the Evidence for DIC Provisional guidance on ISTH for coagulation abnormalities associated with COVID-19] (2020) (0)
- criteria is to serve the platform to study DIC, and to perform the uni- (2012) (0)
- TPN SUPPLEMENTED WITH MEDIUM CHAIN TRIGLYCERIDE PREVENTS THE ATROPHY OF INTESTINAL MUCOSA IN SEPTIC RAT.: 104 (1996) (0)
- THE EVALUATION OF BCA225 AS A NEW TUMORMARKER IN BREAST CARCINOMA (1990) (0)
- How to manage coagulopathies in critically ill patients (2023) (0)
- SUCCESSFUL TREATMENT OF FOURNIER GANGRENE BY MULTIDISCIPLINARY CO-OPERATION (2013) (0)
- Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines (2022) (0)
- [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer]. (1995) (0)
- Therapeutic approach to the septic organ dysfunction by anti-coagulant therapy (2008) (0)
- Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion for Micro-Preemie Infants with Septic Shock. Is Extended Duration Better than Early Start? Comment to the Letter to the Editor of Nishizaki and Colleagues (2021) (0)
- Diagnosis of Sepsis by AI-Aided Proteomics Using 2D Electrophoresis Images of Patient Serum Incorporating Transfer Learning for Deep Neural Networks (2021) (0)
- Communication from the SSC of the ISTH on vascular endothelium-related biomarkers in DIC (2022) (0)
- Biochemical modulation for 5-FU No. 1 : Mechanism and clinical application of MTX/5-FU sequential chemotherapy (1996) (0)
- A case of developmental defect of the body and tail of the pancreas (1990) (0)
- [The differences between Japanese and European guidelines]. (2011) (0)
- The authors reply (2020) (0)
- A CASE OF MALIGNANT FIBROUS HISTIOCYTOMA ARISED IN THE MALE BREAST (1991) (0)
- Thrombin-Antithrombin System (2020) (0)
- EFFECTS OF ANTITHROMBIN ON VASOACTIVE SUBSTANCES PRODUCTION IN ENDOTOXEMIC RATS.: 136 (1999) (0)
- The Significance of Humoral Mediators in Gram-Positive Infection (1993) (0)
- The role of neutrophil in activation of coagulation and thrombus formation (2016) (0)
- Bleeding complications of anticoagulant therapy in sepsis-induced disseminated intravascular coagulation (2016) (0)
- CLINICAL SIGNIFICANCE OF DETERMINATION OF HEPATOCYTE GROWTH FACTOR IN SEPTIC PATIENTS WITH HEPATIC FAILURE.: 163 (1995) (0)
- Effects of Total Parenteral Nutrition (TPN) Supplemented with Medium-Chain Triglyceride (MCT) in Rats with Endotoxin-Induced Sepsis (1997) (0)
- Evaluation of surgical stress in laparoscopic-assisted colectomy for advanced colorectal cancer (2005) (0)
- Prevention of venous thromboembolism (VTE) in ICU: an overview of newly developed anticoagulants (2012) (0)
- Juntendo Medical Journal (2014) (0)
- Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective? (2014) (0)
- Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin (2022) (0)
- Natural history of disseminated intravascular coagulation diagnosed by the newly established diagnostic criteria for critically ill patients (2008) (0)
- Clinical Usefulness of Determining the Level of Hepatic Growth Factor in Septic Patients with Hepatic Failure (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Toshiaki Iba?
Toshiaki Iba is affiliated with the following schools:
